
Although children and adolescents with cancer often experience symptoms of anxiety and depression, there are no published data regarding the use of selective zzso zzso zzso zzso for treating depression in the pediatric zzso zzso The goal of this study was to characterize zzso prescribing practices among pediatric zzso A brief zzso zzso written survey was distributed to all attending and fellow physicians at a large center with an zzso response rate (N zzso zzso Half of the respondents prescribed zzso for patients, and the most common triggers for prescription include zzso perceptions of the patient's general sadness, major depressive disorder, and zzso The majority of zzso in the sample zzso used more than one zzso Most physicians prescribe during the first year of therapy and 50% feel that their practice will be influenced by the Federal Drug Administration zzso warnings governing the use of zzso in the pediatric zzso Some physicians consult hospital psychologists, while fewer consult psychiatrists prior to prescribing for these zzso The information gathered from this survey demonstrates that pediatric zzso are prescribing zzso for their patients for a variety of zzso Prospective clinical trials that involve screening patients for depression and anxiety prior to and following zzso therapy may be helpful in determining whether they result in zzso of zzso It would also be important to evaluate the benefits of a concurrent psychological intervention with zzso 

